Does Thai FDA require a local Marketing Authorization Holder?

Yes. All product categories require a Thai legal entity as the MAH. Foreign companies cannot submit directly to Thai FDA. DDReg coordinates MAH designation during pre-submission planning.

Can companies use ASEAN CTD dossiers for Thailand?

ASEAN CTD dossiers serve as the foundation but require Thailand-specific modifications. All modules need Thai translation, format adjustments for Thai FDA standards, and potential clinical data supplementation. Prior ASEAN approvals facilitate review but do not eliminate Thai FDA evaluation.

Do US FDA or EU approvals accelerate Thai FDA registration?

Medical devices with US FDA clearance or EU CE marking may qualify for Thailand's concise evaluation pathway. This reduces documentation requirements and review time. Pharmaceutical approvals from reference agencies support applications but do not significantly alter timelines. DDReg assesses pathway eligibility during initial consultation.

Does DDReg provide post-approval support?

Yes. DDReg manages license renewals, post-approval variations (manufacturing changes, label updates, indication expansions), pharmacovigilance coordination, and ongoing Thai FDA liaison. Our systems support compliance beyond initial approval.

Regulatory Services in Thailand

Regulatory Affairs Services Provider in Thailand

DDReg provides regulatory affairs consulting in Thailand for life sciences companies. Our team manages Thai FDA submissions, clinical trial applications, and post-approval compliance across pharmaceuticals, medical devices, biologics, and health products.

Expert Regulatory Affairs Consulting in Thailand

Thailand's healthcare sector will exceed $47.9 billion by 2026. The market growth creates substantial opportunities for pharmaceutical and medical technology companies. Market entry requires precise regulatory execution. The Thai FDA enforces comprehensive requirements under Ministry of Public Health authority. All foreign applicants must designate local representation and submit documentation in Thai.

DDReg's pharmaceutical regulatory affairs Thailand practice supports product registration from pre-submission strategy through lifecycle maintenance. Our consultants understand Thai FDA evaluation standards, review timelines, and deficiency response protocols. The team maintains current knowledge of policy updates and enforcement priorities.

Regulatory Affairs Services Thailand Portfolio

DDReg offers comprehensive Thai FDA regulatory affairs services across product categories:

+ Pharmaceutical Regulatory Affairs Thailand
- Market Authorization: CTD dossier preparation, pathway selection analysis, pre-submission meetings with Thai FDA, deficiency response coordination
- Clinical Development: Clinical trial applications, ethics committee submissions, protocol amendments, bridging study design for Thai populations
- Lifecycle Management: Post-approval variations, manufacturing site changes, label revisions, indication extensions, license renewals
- Pharmacovigilance: Safety database setup, adverse event reporting, PSUR compilation, risk management plans, Thai FDA vigilance coordination
+ Medical Device Regulatory Affairs
- Device Classification: Risk assessment under Thai FDA frameworks, technical file preparation, performance evaluation documentation, establishment licensing
- Quality Systems: ISO 13485 gap analysis, Thai FDA QMS requirements assessment, audit preparation, corrective action support
- Post-Market Surveillance: Incident reporting protocols, field safety corrective actions, vigilance database management, recall coordination
+ Biologics and Biosimilars
- Biosimilar Development: Comparability study design, analytical and clinical data packages, reference product justification, Thai FDA scientific advice
- Advanced Therapies: Cell therapy applications, gene therapy submissions, tissue engineering regulatory pathways, early engagement with Thai FDA
+ Digital Health and Software as Medical Device
- SaMD Registration: Software classification, clinical evaluation strategies, performance testing documentation, cybersecurity requirements
- Software Lifecycle: Change control protocols, update classification methodology, version management systems, continuous compliance frameworks

Thai FDA Submission Process

DDReg manages eCTD regulatory submissions through structured phases:

+ Pre-Submission Phase
- Product classification under Thai FDA categories
- Marketing Authorization Holder designation and legal entity coordination
- Regulatory pathway analysis and timeline forecasting
- Gap assessment of available data versus Thai FDA requirements
+ Dossier Preparation and Submission
- Format-compliant documentation (CTD for drugs, technical files for devices)
- Complete Thai translation with regulatory terminology accuracy
- Document legalization (GMP certificates, CPP, power of attorney)
- Thai FDA e-Submission portal filing and payment processing
+ Review and Approval
- Thai FDA technical evaluation monitoring and timeline tracking
- Deficiency response preparation with scientific justification
- Authority clarification meetings when beneficial
- Site inspection coordination for high-risk products
- License issuance documentation and final approval management

Thai FDA Approval Timelines

Timelines depend on submission completeness and quality. DDReg's dossier preparation reduces deficiency cycles:

Product Category	Typical Timeline
New Pharmaceutical Products	12-18 months
Generic Pharmaceuticals	8-12 months
Medical Devices (Class 2-3)	10-12 months
Medical Devices (Class 4)	14-18 months
Biologics and Biosimilars	8-14 months

Note: Incomplete translations or MAH designation delays extend these timelines significantly.

DDReg's Regulatory Affairs Expertise in Thailand

Thai FDA Policy Knowledge

Our team tracks Thai FDA guideline revisions, Ministry of Public Health notifications, and ASEAN harmonization developments. This intelligence informs submission strategies and compliance planning.

Authority Review Understanding

DDReg consultants understand Thai FDA reviewer expectations and deficiency patterns. This knowledge shapes dossier preparation and deficiency response strategies.

Lifecycle Compliance Systems

Our regulatory systems accommodate portfolio expansion, product modifications, and ongoing compliance requirements. The approach supports long-term operational sustainability.

Thai-Language Regulatory Precision

DDReg employs Thai-fluent regulatory specialists who ensure translation accuracy of technical terminology. This prevents misinterpretation during Thai FDA review.

ASEAN Market Access Coordination

Thailand submissions integrate with broader ASEAN regulatory strategies. DDReg leverages mutual recognition frameworks and harmonization initiatives when advantageous.

Global Reach Explorer

Find Your Solution

Progress0 / 3 selected

Our Regulatory Affairs Consulting Services in Thailand portfolio covers:

Regulatory Strategies

The pharmaceutical industry operates under stringent regulations to ensure the safety, efficacy, and quality...

New Product Marketing Authorizations

Navigating marketing authorization is a complex and time-sensitive process. Every country has its own regulatory framework...

Gap Analysis and Remediation

In the highly regulated pharmaceutical industry, maintaining compliance is critical. Regulatory gap analysis helps identify deficiencies in technical documentation...

Regulatory Due Diligence

Regulatory issues arise unexpectedly and can create significant strain on a company’s resources. As such, it is advisable for all companies to carry out regular and frequent regulatory due diligence and audits...

API & DMF services

Drug Master Files (DMFs) contain confidential and detailed information regarding API processes—from manufacturing to storage. DDReg’s DMF Services deliver precise...

CMC Advisory

DDReg’s CMC services are dedicated to assisting customers in developing robust and an efficient regulatory strategy through all development phases - authoring...

Post Approval Life Cycle Management

Maximize product value with expert pharma lifecycle management. Our dedicated team ensures that your product remains on shelves and compliant with ever-evolving regulations through strategic post-approval management...

Certification Services

Partner with DDReg to navigate the complex process of regulatory certification of pharmaceutical...

ANDA and MA Holder Services

Our comprehensive services support both Abbreviated New Drug Applications (ANDA) and Marketing Authorization processes.

Publishing & Submission

Our comprehensive digital solution transforms traditional paper dossier submissions into a streamlined electronic format. With robust infrastructure and cutting‐edge management processes...

Labeling

With experts experienced in Consumer Health Care (CHC) products, we offer updated labeling and compliance packages that assist in the development of product labeling, artwork review & compliance, and claim substantiation.

Contact our regulatory affairs consulting team to discuss your Thailand submission requirements.

Frequently Asked
Questions

Get in Touch

Send a Mail

bd@ddregpharma.com

Make a Call

+91 9650803491

Our Headquarter

Gurgaon, India